Senna-S

Manufacturer: Meijer, Inc. | Geri-Care Pharmaceutical Corp
Effective date: 2025-03-24
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-06-01 00:57:41

Label at a glance#

ProductSenna-S

Active ingredientSENNOSIDES, DOCUSATE SODIUM

Label structure9 sections

Indications and uses

relieves occasional constipation (irregularity) this product generally produces a bowel movement in 6 to 12 hours

Dosage and administration

• do not exceed 8 tablets in 24 hours Age Starting Dose Maximum Dose adults and children 12 years of age and older 2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor 4 tablets in the morning and 4 tablets at bedtime children under 12 years ask a doctor

Storage and handling

each tablet contains: calcium 20 mg, sodium 3 mg store at controlled room temperature Tamper Evident: Do not use if imprinted seal under cap is missing or broken.

Contacts and useful links#

PhoneLabel contact1-800-540-3765

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Docusate Sodium 50 mg
Sennosides 8.6 mg

Purpose

OTC - PURPOSE SECTION

Stool softener

Laxative

Uses

INDICATIONS & USAGE SECTION

relieves occasional constipation (irregularity)

this product generally produces a bowel movement in 6 to 12 hours

Warnings

WARNINGS SECTION

Do not use for more than one week unless directed by a doctor.

Ask a doctor before use if you

have abdominal pain, nausea or vomiting
are taking mineral oil
have noticed a sudden change in bowel habits that lasts over two weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative.
These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

• do not exceed 8 tablets in 24 hours

Age	Starting Dose	Maximum Dose
adults and children 12 years of age and older	2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor	4 tablets in the morning and 4 tablets at bedtime
children under 12 years	ask a doctor

Other information

STORAGE AND HANDLING SECTION

each tablet contains: calcium 20 mg, sodium 3 mg
store at controlled room temperature

Tamper Evident: Do not use if imprinted seal under cap is missing or broken.

Inactive ingredients

INACTIVE INGREDIENT SECTION

cellulose, croscarmellose sodium, dicalcium phosphate, FD&C yellow #6 lake, hypromellose, magnesium stearate, PEG, silica, talc, titanium dioxide.

Questions or comments?

OTC - QUESTIONS SECTION

1-800-540-3765

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	2
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	2
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
79481-0555-6	Senna-S	60 in 1 BOTTLE	TABLET	60		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
79481-0555	SENNA-S (SENNOSIDES AND DOCUSATE SODIUM) TABLET [MEIJER, INC.]	2	Current NDC, 1 package rows	20250326_2619be6e-877b-16a2-e063-6394a90a68da.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

Senna-S
Sennosides and Docusate Sodium
CELLULOSE, MICROCRYSTALLINE
CROSCARMELLOSE SODIUM
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
HYPROMELLOSES
FD&C YELLOW NO. 6
TITANIUM DIOXIDE
TALC
SENNOSIDES
DOCUSATE SODIUM
DOCUSATE
SILICON DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
79481-0555	79481-0555-6

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	L11K75P92J	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
POLYETHYLENE GLYCOL, UNSPECIFIED	3WJQ0SDW1A	IACT
HYPROMELLOSES	3NXW29V3WO	IACT
FD&C YELLOW NO. 6	H77VEI93A8	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
TALC	7SEV7J4R1U	IACT
SENNOSIDES	3FYP5M0IJX	ACTIB
DOCUSATE SODIUM	F05Q2T2JA0	ACTIB
SILICON DIOXIDE	ETJ7Z6XBU4	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Senna-S	SENNOSIDES AND DOCUSATE SODIUM	Meijer, Inc.	2619be6e-877b-16a2-e063-6394a90a68da	2025-03-24	Warnings	Exact identifier ndc (package): 79481-0555-6 ndc (product): 79481-0555 ndc11 (package): 79481055506 spl id: 31189725-3e17-4c9f-e063-6394a90a9149 spl set id: 2619be6e-877b-16a2-e063-6394a90a68da

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.